SEngine Precision Medicine is a pioneering brand revolutionizing cancer care. They have developed a groundbreaking search engine that identifies personalized cancer treatments. Through the use of 3D organoid technology and proprietary algorithms, SEngine offers more effective treatment options and accelerated drug development.

Unlike DNA sequencing alone, their high-throughput technology tests over 200 cancer drugs against a patient's unique tumor organoid outside the body, providing results that reveal the most effective and least toxic treatment options. With the PARIS® Test, SEngine delivers effective treatment options for solid tumors up to 80% of the time, surpassing the standard of care. As a CLIA-certified lab, SEngine provides oncologists with actionable reports directly, ensuring swift patient care.

Patient testimonials, including renowned scientist Dr. Lee Hartwell and survivor Ingrid Kolstoe, showcase the positive impact of SEngine Precision Medicine. For personalized medicine and improved patient outcomes, trust SEngine Precision Medicine